American Cannabis Company, Inc.: management transactions · United States · SEC (Form 4)

About American Cannabis Company, Inc.

American Cannabis Company, Inc. is a U.S.-based microcap focused on ancillary services and solutions for the regulated cannabis industry in the United States. The company is headquartered in Colorado Springs, Colorado, and is incorporated in Delaware. It trades under the ticker AMMJ on the OTC Markets venue rather than on NYSE or NASDAQ, which makes it a lower-liquidity, higher-risk profile for investors comparing it with mainstream exchange-listed equities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm)) The company’s origins date back to 2001, when it was formed as Naturewell, Inc. Its current identity was established through a major corporate reset in 2014: following a reverse merger and a divestiture of the legacy business, the company adopted the name American Cannabis Company, Inc. and refocused on the legal cannabis ecosystem. This history matters because it clarifies the business model: the company is not a cannabis cultivator or retailer, but a B2B service provider built around consulting, facility design, and ancillary products. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm)) American Cannabis Company’s core business lines are advisory and consulting services for licensed operators and applicants seeking cannabis licenses, along with the design of cannabis-specific facilities and the sale of ancillary products used in the industry. The company also describes a strategic partnership framework that gives it access to both exclusive and non-exclusive products commonly used by cannabis businesses. In investment terms, this is a “picks and shovels” model, which aims to monetize industry growth without taking on the direct operating risks of cultivation, inventory, or retail execution. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm)) From a competitive standpoint, the company operates in a fragmented niche that includes specialist consultants, equipment suppliers, and local service providers. Its differentiation likely comes from sector expertise, regulatory familiarity, and end-to-end support for operators navigating licensing and compliance requirements. The trade-off is scale: as a small company, it has limited brand power, financial resources, and market penetration versus larger multi-state cannabis operators or broader industrial service providers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm)) Recent developments have centered on corporate governance rather than major commercial expansion. A Form 8-K filed on May 8, 2026 states that Joe Cleghorn stepped down as CEO, remained Chairman of the Advisory Board, and that James Woodend was appointed CEO and Chairman of the Board, effective immediately. For investors, this leadership change is meaningful because it may indicate a new operating cadence or strategic direction. Public disclosures available as of now emphasize management transition more than any material new product launch or major revenue catalyst. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm))